Stay updated with breaking news from Johnc Klock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) is set to issue its quarterly earnings data after the market closes on Wednesday, April 26th. Analysts expect the company to announce earnings of $0.43 per share for the quarter. BioMarin Pharmaceutical has set its FY 2023 guidance at $1.80-$2.05 EPS.Individual that wish to register for the company’s earnings […]
Emerald Advisers LLC bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 8,845 shares of the biotechnology company’s stock, valued at approximately $915,000. Other hedge funds and other institutional investors have also recently bought […]
DekaBank Deutsche Girozentrale boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 2.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 296,567 shares of the biotechnology company’s stock after buying an additional 7,280 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in BioMarin Pharmaceutical were worth $30,273,000 as of its […]
Redwood Wealth Management Group LLC purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,172 shares of the biotechnology company’s stock, valued at approximately $328,000. Other hedge funds also […]
Dupont Capital Management Corp lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 83.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 517 shares of the biotechnology company’s stock after selling 2,649 shares during the quarter. Dupont Capital Management Corp’s […]